BE724364A - - Google Patents

Info

Publication number
BE724364A
BE724364A BE724364A BE724364A BE724364A BE 724364 A BE724364 A BE 724364A BE 724364 A BE724364 A BE 724364A BE 724364 A BE724364 A BE 724364A BE 724364 A BE724364 A BE 724364A
Authority
BE
Belgium
Application number
BE724364A
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of BE724364A publication Critical patent/BE724364A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE724364A 1967-11-24 1968-11-22 BE724364A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT1064767A AT280290B (de) 1967-11-24 1967-11-24 Verfahren zur Herstellung von neuen 1-Phenyl-4-alkyl-3H-1,4-benzodiazepin-2,5-[1H,4H]-dionen

Publications (1)

Publication Number Publication Date
BE724364A true BE724364A (fr) 1969-05-22

Family

ID=3623762

Family Applications (1)

Application Number Title Priority Date Filing Date
BE724364A BE724364A (fr) 1967-11-24 1968-11-22

Country Status (13)

Country Link
AT (1) AT280290B (fr)
BE (1) BE724364A (fr)
BR (1) BR6804236D0 (fr)
CH (1) CH523265A (fr)
DE (1) DE1810423B2 (fr)
DK (1) DK124950B (fr)
ES (2) ES360410A1 (fr)
FR (2) FR1593335A (fr)
GB (1) GB1173540A (fr)
IE (1) IE32504B1 (fr)
IL (1) IL31146A (fr)
NL (1) NL6815755A (fr)
SE (1) SE356979B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3914216A (en) * 1962-12-18 1975-10-21 Boehringer Sohn Ingelheim 1-Phenyl-3H-1,4-benzodiazepine-2,5-(1H,4H)-diones
DE2117438A1 (de) * 1971-04-08 1972-10-19 CH. Boehringer Sohn, 6507 Ingelheim Neue substituiert 1,3-Dihydro-2H-1 ^-benzodiazepine^-one
BE793460A (fr) * 1971-12-29 1973-06-28 Boehringer Sohn Ingelheim Nouvelles 1-aryl-3h,1,4-benzodiazepine-2,5-(1h
US7276348B2 (en) 1999-04-30 2007-10-02 Regents Of The University Of Michigan Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof
US20060025388A1 (en) 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
AU782447C (en) * 1999-04-30 2006-07-13 Regents Of The University Of Michigan, The Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
US7572788B2 (en) 1999-04-30 2009-08-11 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US7691582B2 (en) 2002-09-27 2010-04-06 The Regents Of The University Of Michigan Methods of secretory vimentin detection and modulation
WO2006074358A1 (fr) 2005-01-03 2006-07-13 The Regents Of The University Of Michigan Compositions et procedes concernant de nouveaux composes et leurs cibles
US20070043033A1 (en) 2005-06-01 2007-02-22 The Regents Of The University Of Michigan Unsolvated benzodiazepine compositions and methods
EP1948191B1 (fr) 2005-11-01 2013-01-16 The Regents of the University of Michigan Nouvelles 1,4-benzodiazépine-2,5-diones dotées de propriétés thérapeutiques
US7759338B2 (en) 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
NZ573452A (en) 2006-06-09 2011-09-30 Univ Michigan Compositions and methods relating to novel compounds and targets thereof
US7851465B2 (en) 2007-03-09 2010-12-14 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
MX2009011923A (es) * 2007-05-10 2009-11-18 Amr Technology Inc Tetrahidrobenzo-1,4-diazepinas aril- y heteroaril-sustituidas y uso de las mismas para bloquear reabsorcion de norepinefrina, dopamina y serotonina.
AU2008298870C1 (en) 2007-09-14 2014-10-09 The Regents Of The University Of Michigan F1F0-ATPase inhibitors and related methods
US8188072B2 (en) 2007-11-06 2012-05-29 The Regents Of The University Of Michigan Benzodiazepinone compounds useful in the treatment of skin conditions
US8497307B2 (en) 2008-09-11 2013-07-30 The Regents Of The University Of Michigan Aryl guanidine F1F0-ATPase inhibitors and related methods
US8604023B2 (en) 2009-04-17 2013-12-10 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
JP2013505258A (ja) 2009-09-18 2013-02-14 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン ベンゾジアゼピノン化合物およびそれを使用する治療方法
CA2780287C (fr) 2009-11-17 2015-03-17 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones et composes apparentes presentant des proprietes therapeutiques
CN102753179A (zh) 2009-11-17 2012-10-24 密执安大学评议会 具有治疗性能的1,4-苯并二氮杂*-2,5-二酮和相关化合物
EP3043790B1 (fr) 2013-09-11 2021-05-26 The Administrators of the Tulane Educational Fund Nouveaux amides anthraniliques et utilisation de ces derniers

Also Published As

Publication number Publication date
FR8310M (fr) 1970-11-23
NL6815755A (fr) 1969-05-28
IL31146A0 (en) 1969-01-29
DE1810423B2 (de) 1973-03-22
BR6804236D0 (pt) 1973-02-08
FR1593335A (fr) 1970-05-25
IL31146A (en) 1972-04-27
ES360410A1 (es) 1970-11-01
IE32504L (en) 1969-05-24
ES378977A1 (es) 1973-01-16
DE1810423C3 (fr) 1973-10-11
AT280290B (de) 1970-04-10
DE1810423A1 (de) 1969-10-09
SE356979B (fr) 1973-06-12
IE32504B1 (en) 1973-08-22
GB1173540A (en) 1969-12-10
CH523265A (de) 1972-05-31
DK124950B (da) 1972-12-11

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
FR8310M (fr)
AU416737B2 (fr)
AU342066A (fr)
AU610966A (fr)
BE707804A (fr)
BE693070A (fr)
BE162295A (fr)
BE426053A (fr)
BE711252A (fr)
AU97666A (fr)
BE477645A (fr)
BE711032A (fr)
AU459699A (fr)
BE711020A (fr)
BE709997A (fr)
BE709967A (fr)
BE709359A (fr)
BE707014A (fr)
BE483855A (fr)
BE705572A (fr)
BE704337A (fr)
BE701102A (fr)
BE693071A (fr)
BE711310A (fr)